HLA
COVID-19 Protection Provided by HLA Genetic Variant, Study Suggests
Using data from bone marrow registry participants, researchers found an HLA variant linked to symptom-free SARS-CoV-2 infection and better immune cell responses.
Tempus, TScan Therapeutics Partner on CDx for T-Cell Receptor Therapy in Solid Tumors
The companies will collaborate to develop a companion diagnostic to support TScan's screening protocol for its Phase 1 solid tumor clinical trial.
The company has identified numerous immunogenic peptides derived from transposable elements at the surfaces of cancer cells.
Somatic Mutations in Lung Cancer Patients With HLA Supertype B44 Influence Immunotherapy Response
The B44 supertype is associated with improved survival in melanoma patients treated with immunotherapy, but less so in NSCLC patients, due to mutational differences.
CareDx Hybrid Capture Tech for HLA Testing Receives CE Marking
The company, which launched the technology in September 2019, said in its Q4 earnings release that it received high marks from beta testers.
Jun 15, 2018
May 10, 2018
CareDx Q1 Revenues Up 21 Percent
Jun 9, 2015
Linkage Bio Receives CE Mark for HLA Test
Apr 21, 2011
Sep 30, 2010